ARMISTICE CAPITAL LLC 13D and 13G filings for Windtree Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:44 pm Purchase | 2024-12-31 | 13G | Windtree Therapeutics, Inc. WINT | ARMISTICE CAPITAL LLC | 5,771 2.550% | 371 (+6.87%) | Filing |
| 2024-11-14 3:40 pm Purchase | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | ARMISTICE CAPITAL LLC | 5,400 7.120% | 5,400 (New Position) | Filing |